Browsing by Subject "rabeprazole"

Now showing items 1-13 of 13

A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease

Kobeissy A.A.; Hashash J.G.; Jamali F.R.; Skoury A.M.; Haddad R.; El-Samad S.; Ladki R.; Aswad R.; Soweid A.M. (BEIJINGRM 903, BLDG D, OCEAN INTERNATIONAL CTR, NO 62 DONGSIHUAN ZHONGLU, BEIJING, CHAOYANG DISTRICT 100025, PEOPLES R CHINA, 2012)

AIM: To compare the efficacy of the proton-pump inhibitor, rabeprazole, with that of the H 2-receptor antagonist, ranitidine, as on-demand therapy for relieving symptoms associated with non-erosive reflux disease (NERD). ...
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection

Mansour N.M.; Hashash J.G.; El-Halabi M.; Ghaith O.; Maasri K.; Sukkarieh I.; Malli A.; Sharara A.I. (PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2011)

OBJECTIVES: To evaluate the efficacy and safety of a standard-dose versus half-dose 10-day triple regimen for the eradication of Helicobacter pylori infection. METHODS: A total of 115 consecutive patients with documented ...
Acute NSAID-related transmural duodenitis and extensive duodenal ulceration

Hashash J.G.; Atweh L.A.; Saliba T.; Chakhachiro Z.; Al-Kutoubi A.; Tawil A.; Barada K.A. (BRIDGEWATER685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA, 2007)

Background: A 40-year-old previously healthy white man presented to the emergency department at American University of Beirut Medical Center, Beirut, Lebanon, with severe upper abdominal pain of 36-hour duration. The pain ...
Atorvastatin-induced severe gastric ulceration: A case report

El-Hajj I.I.; Mourad F.H.; Shabb N.S.; Barada K.A. (BEIJINGRM 903, BLDG D, OCEAN INTERNATIONAL CTR, NO 62 DONGSIHUAN ZHONGLU, BEIJING, CHAOYANG DISTRICT 100025, PEOPLES R CHINA, 2005)

A 41-year-old man presented with severe gastric ulceration 3 mo after beginning treatment with atorvastatin 20 mg once daily for hypercholesterolemia. The patient was not taking any ulcerogenic drugs and had no evidence ...
CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel

El-Halabi M.M.; Zgheib N.; Mansour N.M.; Malli A.; Ghaith O.A.; Mahfouz R.; Alam S.; Sharara A.I. (PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2013)

The aim of this study is to investigate the effect of CYP2C19 polymorphism and cotherapy with rabeprazole or esomeprazole on the antiplatelet effect of clopidogrel. Patients receiving clopidogrel 75 mg ± rabeprazole or ...
Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication

Sharara A.I.; Chaar H.F.; Aoun E.; Abdul-Baki H.; Araj G.F.; Kanj S.S. (OXFORD9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND, 2006)

Objectives: To evaluate the efficacy of a 7-day regimen of gatifloxacin (400 mg daily), amoxicillin (1 g twice a day), and rabeprazole (20 mg twice a day) in the secondary eradication of Helicobacter pylori infection. ...
Efficacy of two rabeprazole-gatifloxacin-based triple therapies for Helicobacter pylori infection

Sharara A.I.; Chaar H.F.; Racoubian E.; Moukhachen O.; Barada K.A.; Mourad F.H.; Araj G.F. (MALDEN350 MAIN ST, MALDEN, MA 02148 USA, 2004)

Objectives. To evaluate the efficacy of two novel treatment regimens consisting of gatifloxacin (400 mg daily), amoxicillin (1 g twice daily), and rabeprazole 20 mg once (RAG20) or twice daily (RAG40) given for 7 days in ...
Pharmacogenetics and personalized medicine: The future for drug prescribing

Mitri Z.; Esmerian M.O.; Simaan J.A.; Sabra R.; Zgheib N.K. (, 2010)

Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend ...
Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study

Sharara A.I.; El-Halabi M.M.; Ghaith O.A.; Habib R.H.; Mansour N.M.; Malli A.; El Hajj-Fuleihan G. (PHILADELPHIA1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA, 2013)

Objectives: Proton pump inhibitors (PPIs) are associated with an increased risk of bone fractures. This study sought to evaluate the effect of PPIs on biochemical markers of calcium and bone metabolism. Methods: Prospective ...
Rabeprazole: The role of proton pump inhibitors in Helicobacter pylori eradication

Sharara A.I. (, 2005)

Proton pump inhibitors have become one of the cornerstones in the treatment of Helicobacter pylori infection. Rabeprazole (Pariet®) is a substituted benzimidazole proton pump inhibitor with potent gastric acid suppression ...
Spontaneous abdominal hematoma in a patient treated with clopidogrel and aspirin [5]

Otrock Z.K.; Sawaya J.I.; Zebian R.C.; Taher A.T. (NEW YORK233 SPRING STREET, NEW YORK, NY 10013 USA, 2006)

[No abstract available]
The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication

El-Zahabi L.M.N.; Jamali F.R.; El-Hajj I.I.; Naja M.; Salem Z.; Shamseddine A.; El Saghir N.S.; Zaatari G.; Geara F.; Soweid A.M. (NEW YORK360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA, 2007)

Background: Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is associated with Helicobacter pylori infection, and regression of the tumor has been described after its eradication. Objective: To determine the value ...
Upper gastrointestinal bleeding in patients with acute coronary syndromes: Clinical predictors and prophylactic role of proton pump inhibitors

Barada K.; Karrowni W.; Abdallah M.; Shamseddeen W.; Sharara A.I.; Dakik H.A. (, 2008)

OBJECTIVES: To determine the risk and the clinical predictors of in-hospital upper gastrointestinal (UGI) bleeding in patients with acute coronary syndromes (ACS), and to study the prophylactic role of proton pump inhibitors ...

Now showing items 1-13 of 13

Search AUB ScholarWorks

Browse

All of AUB ScholarWorks

My Account

Copyright Statement

All materials included in the institutional repository are protected by copyright laws and are the property of their respective copyright holders. Materials may be used for non-commercial, educational, or research purposes only, and must be cited or attributed to the original source. Permission for any other use must be obtained from the copyright holder(s) directly. The American University of Beirut Libraries does not assume responsibility for any infringement of copyright laws that may occur as a result of the use of materials in the repository. If you believe that your copyright has been infringed upon in the repository, please contact the AUB Libraries immediately.

For further information, please contact us at scholarworks@aub.edu.lb

Browsing by Subject "rabeprazole"

Browsing by Subject "rabeprazole"

Search AUB ScholarWorks

Browse

All of AUB ScholarWorks

My Account

Copyright Statement